Bacterial Infections in Patients with Cirrhosis in Argentina: Clinical and Microbiological Characteristics

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

472 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-10-16

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In recent years, there has been an increasing prevalence of bacterial infections caused by multiresistant and extremely resistant organisms in patients with cirrhosis. These infections are associated with a worse prognosis, generate difficulties in the management of the patient during hospitalization and increase health costs.

The main objective of this project is to estimate the prevalence of infections by multiresistant bacteria in patients with cirrhosis. Additionally, the prevalence of other antibiotic resistance patterns and morbi-mortality in the study population will be evaluated.

For these purposes, a multicenter prospective cohort study will be carried out, including patients with cirrhosis who present bacterial infections at the time of admission, or during hospitalization.

Performing a study in Argentina on the clinical and microbiological characteristics of bacterial infections in patients with cirrhosis could be very useful to develop new strategies for prevention and treatment of this severe complication.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Bacterial Infections in Cirrhotic Patients With Acute Severe Liver Injury

NCT03204591

Cirrhosis, Liver Bacterial Infections Acute Liver Injury

UNKNOWN

Antimicrobial Resistance in Cirrhotic Patients

NCT04915573

Cirrhosis

UNKNOWN

Liver Injury in Patients With COVID-19

NCT04358380

Liver Injury

UNKNOWN

Evaluation of Cardiac Function in Acutely Decompensated Cirrhosis

NCT05413083

Cirrhosis Acute Liver Failure Cardiomyopathies

ACTIVE_NOT_RECRUITING

Infections in Hospitalized Cirrhotic Patients

NCT03137719

Cirrhosis

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bacterial Infections Cirrhosis Resistant Infection Morality

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

This is an observational study without intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with cirrhosis
* Patients older than 17 years.
* Patients who are hospitalized for bacterial infections, or who develop bacterial infections while hospitalized